Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q2 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.16 million versus the consensus estimate of $1.16 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.